Although Indonesia's investment climate poses challenges, the pharmaceutical industry is regarded to contain lucrative opportunities because the Indonesian government is eager to turn its ambitious universal healthcare scheme into a success. Indonesia is the world’s fourth-most populous nation. Development of public healthcare in combination with an expanding middle class (amid the nation's solid economic growth) should imply that Indonesia’s pharmaceutical sector contains ample potential for further growth.
Pharmacetuical plants rely on continuous and batch production processes, each posing different requirements for a control system. A continuous process calls for a robust and stable control system that will not fail and cause the shutdown of a production line, whereas the emphasis with a batch process is on having a control system that allows great flexibility in making adjustments to formulas, procedures, and the like. Both kinds of systems need to be managed in available quality history of product, and to be able to execute non-routine operations. Our product offer the solution of any plant issues.